There is 1 version of this bill. View text

Click the check-box to add or remove the section, click the text link to scroll to that section.
Titles Actions Overview All Actions Cosponsors Committees Related Bills Subjects Latest Summary All Summaries

Titles (2)

Short Titles

Short Titles - Senate

Short Title(s) as Introduced

American Cures Act

Official Titles

Official Titles - Senate

Official Titles as Introduced

A bill to prioritize funding for an expanded and sustained national investment in biomedical research.

Actions Overview (1)

Date Actions Overview
03/24/2021Introduced in Senate

All Actions (1)

Date All Actions
03/24/2021Read twice and referred to the Committee on Appropriations. (text: CR S1770-1771)
Action By: Senate

Cosponsors (6)

* = Original cosponsor
CosponsorDate Cosponsored
Sen. Van Hollen, Chris [D-MD]* 03/24/2021
Sen. Baldwin, Tammy [D-WI]* 03/24/2021
Sen. Brown, Sherrod [D-OH]* 03/24/2021
Sen. Cardin, Benjamin L. [D-MD]* 03/24/2021
Sen. Blumenthal, Richard [D-CT]* 03/24/2021
Sen. Klobuchar, Amy [D-MN]* 03/24/2021

Committees (1)

Committees, subcommittees and links to reports associated with this bill are listed here, as well as the nature and date of committee activity and Congressional report number.

Committee / Subcommittee Date Activity Related Documents
Senate Appropriations03/24/2021 Referred to

As of 07/23/2021 no related bill information has been received for S.962 - American Cures Act

Latest Summary (1)

There is one summary for S.962. View summaries

Shown Here:
Introduced in Senate (03/24/2021)

American Cures Act

This bill permanently funds several federal agencies and programs that perform biomedical research.

The bill provides specified funding for

  • the National Institutes of Health,
  • the Centers for Disease Control and Prevention,
  • the Department of Defense health program, and
  • the Department of Veterans Affairs medical and prosthetics research program.

The bill exempts the funding from sequestration, which is a process of automatic, usually across-the-board spending reductions under which budgetary resources are permanently cancelled to enforce specific budget policy goals.

It also exempts the budgetary effects of the funding from the Statutory Pay-As-You-Go Act of 2010 (PAYGO) and the Senate PAYGO rule.